贝伐珠单抗应用于非小细胞肺癌中的研究进展(4)
[7] Chen JH，Yang JL， Chou CY， et al. Indirect comparison of efficacy and safety between immune checkpoint inhibitors and antiangiogenic therapy in advanced non-small-cell lung cancer[J]. Sci Rep，2018，8(1)：9686.[8] Reck M，Garassino MC，Imbimbo M，et al. Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting[J]. Lung Cancer ......
您现在查看是摘要页，全文长 2545 字符。